Zynex Inc. Declares Zero‑Price Insider Liquidations in Chapter 11 Clean‑Slate Sale, Leaving Investors with Void Shares.

Zynex Inc. Surfaces from Chapter 11 with a Clean‑Slate Sale

On March 26, 2026, Zynex Inc. completed the liquidation of all outstanding shares as part of its Chapter 11 reorganization plan. The transaction, executed by director Barry D. Michaels, saw 80,001 shares sold at $0.00, effectively wiping the company’s share count and cancelling all equity awards. This move follows the company’s 15‑12G filing that confirmed the plan’s effectiveness and the termination of its common‑stock registration. With the stock now delisted, investors who held any shares are left holding either a voided position or, if they had purchased new shares issued to the plan sponsor, an equity that is now subject to a fresh capital structure.

Insider Outflows Reflect a Systemic Reset

The same day, two other insiders—Disbrow Joshua R. and Cress Michael D.—each sold 12,499 restricted shares and 89,501 or 82,501 unrestricted shares, respectively, also at zero price. These large‑scale liquidations, coupled with the director’s own sale, suggest that the reorganization was not merely a procedural reset but an active divestiture of pre‑bankruptcy holdings. The fact that all sales were priced at zero aligns with the cancellation clause in the plan, which forfeits any consideration for pre‑plan shares. Investors can interpret this as the insiders acknowledging that the old equity structure has ceased to exist and that any future ownership will stem from the new issuance under the plan sponsor’s terms.

Implications for Investors and the Company’s Future

From an investor’s perspective, the immediate effect is a total loss of any pre‑plan stake—no cash or shares will be recovered. However, the reorganization’s success could unlock a new capital base and operational focus. The company’s 52‑week low of $0.02 and a year‑over‑year decline of 97.27 % underscore a severe valuation collapse; the reorganization may provide an opportunity for a turnaround, but it also raises the risk that the new structure will remain illiquid, given its OTC Bulletin Board listing and the absence of any forthcoming securities‑market activity.

For those looking at the long‑term prospects, the key question is whether the plan sponsor’s newly issued common stock will attract institutional support or if the company will continue to languish on the OTC market. The current sentiment score of –68 and a buzz level of 200 % indicate heightened investor unease and media scrutiny, which could pressure the company to accelerate a recovery strategy or consider a secondary listing. Until the plan sponsor clarifies the issuance terms and any potential listing upgrade, the company’s future remains uncertain.

Conclusion

Zynex’s Chapter 11 closure and the complete cancellation of its former shares mark the end of one chapter and the uncertain beginning of another. Insider sales at zero price confirm that the pre‑bankruptcy equity is void, while the lack of subsequent trading activity suggests a cautious, restructuring‑focused approach. Investors should weigh the risk of continued illiquidity against the possibility that a fresh equity issuance under the plan sponsor could provide a new platform for growth in the health‑care equipment sector.